Stents, Bare Metal

MGuard Embolic Protection Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Heart Attack Survival

November 1, 2012 — InspireMD Inc. announced that its proprietary MGuard embolic protection stent (EPS) was shown to be significantly superior when compared to standard bare metal and drug-eluting stents in achieving complete ST resolution and rest...

The Future of Coronary Stenting

April 15, 2012, will mark the 10th anniversary of the approval of the first drug-eluting stent (DES). Ten years ago, the mood surrounding the new anti-restinotic silver bullet stent was one of jubilance. The approval of the new drug-eluting stent...

Drug-Eluting Stents Improve Outcomes in Saphenous Vein Graft Lesions

April 8, 2011 – In the largest randomized, multicenter trial to compare drug-eluting stents (DES) and bare-metal stents (BMS) placed in saphenous vein graft lesions, researchers found that DES led to a lower combined rate of death, heart attack an...

Renals: To Stent or Not to Stent?

There is no consensus about whether atherosclerotic renal artery stenosis should be stented or treated medically. There are strong opinions on both sides and clinical data up to now is heavily debated. Many see the trials that could have answered...

Biotronik Announces First U.S. Implants of its Bare Metal...
December 27, 2012 — Biotronik announced that the first implant has taken place in the BIOHELIX-I trial in the United States. The BIOHELIX–I...
Tryton Side Branch Stent TRYTON Pivotal FDA IDE trial
Tryton Completes Patient Enrollment in Pivotal FDA Side...
Tryton Medical Inc. announced the completion of enrollment in the TRYTON Pivotal U.S. Food and Drug Administration (FDA) IDE trial evaluating the Tryton Side...
Svelte Acrobat Bare Metal Stents Svelte Medical Systems Inc
Svelte Medical Systems Announces Approval to Initiate Study...
November 9, 2012 — Svelte Medical Systems announced it received conditional approval from the U.S. Food and Drug Administration (FDA) to begin a pivotal study...
MGuard Embolic Protection Stent Meets Primary Endpoint of...
November 1, 2012 — InspireMD Inc. announced that its proprietary MGuard embolic protection stent (EPS) was shown to be significantly superior when compared to...
FDA Clears Medinol Presillion Coronary Stent
The U.S. Food and Drug Administration (FDA) has approved the premarket approval application (PMA) for the Medinol Ltd. Presillion plus
The Assurant Cobalt Iliac Balloon-Expandable Stent System from Medtronic is the first balloon-expandable stent made from a cobalt-chromium...
RX Herculink Elite Renal Stent For Use Near Ostium
Abbott Vascular’s RX Herculink Elite Renal Stent System is a balloon-expandable, cobalt chromium, laser-cut stent used to re-open narrowed...
Renal Stents Expand Treatment Options
Two new stents renal stents from Cook Medical offer additional options in treating patients with atherosclerotic disease. The Formula...
View All »

Articles

Tryton Side Branch Stent TRYTON Pivotal FDA IDE trial
Tryton Completes Patient Enrollment in Pivotal FDA Side...
Tryton Medical Inc. announced the completion of enrollment in the TRYTON Pivotal U.S. Food and Drug Administration (FDA) IDE trial evaluating the Tryton Side...
MGuard Embolic Protection Stent Meets Primary Endpoint of...
November 1, 2012 — InspireMD Inc. announced that its proprietary MGuard embolic protection stent (EPS) was shown to be significantly superior when compared to...
The Future of Coronary Stenting
April 15, 2012, will mark the 10th anniversary of the approval of the first drug-eluting stent (DES). Ten years ago, the mood surrounding the new anti-...
Cardiovascular Stents – Novel Designs, Polymers and New...
There have been several key news items from the U.S. stent market over the past year. These include the introduction of several new stents, Cordis pulling out...

Video Center

view all Videos »

The Radial Access Adoption Report Card
Over the past decade in the United States, there has been growing interest in transradial artery...
11 weeks 1 day ago
Game-Changing Technologies to Watch in 2013
My job as editor of DAIC is to help readers keep tabs on the latest in cardiovascular technology...
15 weeks 3 days ago
Innovation Exasperation
In a recent LinkedIn Medical Device Group posting, it was noted that DuVal & Associates, P.A....
19 weeks 1 day ago
View All »
EP lab, Tom De potter, depotter, angiography dose reduction
Less is More — Radiation Exposure Reduction in the EP Lab
This webinar focuses on implementation of different strategies to reduce radiation exposure during interventional electrophysiology (EP) procedures. It offers an overview of the current state-of-the-...
Iterative Reconstruction in CT: Understanding and Implementation
Radiation exposure from multidetector CT (MDCT) has become a pressing public health concern in both lay and medical publications. Implementation of iterative reconstruction offers radiologists the...
Healthcare Reform: What’s the Immediate Impact on Cardiovascular IT?
The recent U.S. Supreme Court ruling upholding the 2010 Affordable Care Act (ACA) may have significant impact on healthcare providers and their cardiovascular departments. While the ruling will...

Comparison Charts

Sorry there is no data available